Rights granted for reproduction by any legitimate news organization (or blog, or syndicator). However, if news is cloned/scraped verbatim, then original attribution must be maintained with link back to this page as “original syndication source.” Resale of this content for commercial purposes is prohibited without a license. Reproduction on any site selling a competitive service is also prohibited. This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License.
Story Reads as of 2023-01-29 14:40:48: 2,726 views
REFERENCES: Biotechnology News, Epeius Biotechnologies Corporation, Rexin-G, Rexin G, Dr. Frederick L. Hall, clinical trial, FDA approval, Orphan Drug, tumor-targeted gene delivery system, vector, metastatic tumor nodules, advanced pancreatic cancer, new york news, Targeted Delivery System (TDS), biotech newswire, biotechnology, medtech Epeius Biotechnologies Corporation | ID:4579